Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock
Abstract Background The administration of low-dose intravenous immunoglobulin G (IVIgG) (5 g/day for 3 days; approximate total 0.3 g/kg) is widely used as an adjunctive treatment for patients with sepsis in Japan, but its efficacy in the reduction of mortality has not been evaluated. We investigated...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
BMC
2017-07-01
|
| 丛编: | Critical Care |
| 主题: | |
| 在线阅读: | http://link.springer.com/article/10.1186/s13054-017-1764-4 |
| 标签: |
没有标签, 成为第一个标记此记录!
|
